Latest AI and machine learning research in hepatitis for healthcare professionals.
The rapid deployment of COVID-19 vaccines has necessitated the ongoing surveillance of adverse event...
Predicting major bleeding in nonvalvular atrial fibrillation (AF) patients on direct oral anticoagul...
Interferon (IFN) is a pivotal agent against hepatitis B virus (HBV) in clinic, but there is a lack o...
The viability of cells and the integrity of the genome depend on the detection and repair of damaged...
Hepatitis C virus (HCV) infection represents a significant contributor to chronic liver disease on a...
BACKGROUND: With the increasing application of artificial intelligence (AI) technologies in the heal...
BACKGROUND & AIMS: Accurate prediction of disease severity and prognosis are challenging in patients...
Identifying viral replication within cells demands labor-intensive isolation methods, requiring spec...
BACKGROUND: Early recognition of steatosis (fatty liver) and fibrosis in liver health is crucial for...
Despite the significant success of vaccinations, increasing vaccine hesitancy poses a threat to publ...
INTRODUCTION: Accurate prediction of immunogenic proteins is crucial for vaccine development and und...
Developments in ambulatory electrocardiogram (ECG) technology have led to vast amounts of ECG data t...
The objective was to use convolutional neural networks (CNNs) for automatic segmentation of hip cart...
BACKGROUND: Viral vaccines have been proven significant in protecting us against viral diseases such...
Early diagnosis at the metabolomic level is crucial for the treatment of liver cirrhosis and hepatoc...
Transient receptor potential vanilloid 4 (TRPV4) is a calcium-permeable cation channel critical for ...
BACKGROUND: Cirrhosis is a leading cause of mortality in patients with chronic liver disease (CLD). ...
BACKGROUND: Mumps is a viral respiratory disease characterized by facial swelling and transmitted th...
The global impact of SARS-CoV-2 has highlighted the urgent need for novel antiviral therapies. This ...
BACKGROUND: The global prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 30%,...